[go: up one dir, main page]

0% found this document useful (1 vote)
84 views38 pages

PTL/PPROM and Multifetal Gestation

This document discusses preterm labor/preterm premature rupture of membranes (PTL/PPROM) and multifetal gestation. It provides objectives on identifying risk factors, adverse outcomes of preterm birth, signs/symptoms of PTL/PPROM, management based on gestational age, counseling to reduce risk of preterm birth, and medications used. For multifetal gestation, it lists discussing risk factors, maternal/fetal physiologic changes, diagnosis and management, and potential complications. The case involves a patient presenting with PPROM who is admitted, given betamethasone/magnesium/antibiotics, and later delivers vaginally at 28 weeks.

Uploaded by

Nik C
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (1 vote)
84 views38 pages

PTL/PPROM and Multifetal Gestation

This document discusses preterm labor/preterm premature rupture of membranes (PTL/PPROM) and multifetal gestation. It provides objectives on identifying risk factors, adverse outcomes of preterm birth, signs/symptoms of PTL/PPROM, management based on gestational age, counseling to reduce risk of preterm birth, and medications used. For multifetal gestation, it lists discussing risk factors, maternal/fetal physiologic changes, diagnosis and management, and potential complications. The case involves a patient presenting with PPROM who is admitted, given betamethasone/magnesium/antibiotics, and later delivers vaginally at 28 weeks.

Uploaded by

Nik C
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 38

PTL/PPROM and

Multifetal Gestation

ANNA BUABBUD MD
MS3 LECTURE
PTL/PPROM Objectives

 Identify risk factors


 List the adverse outcomes associated with preterm birth
 List the signs and symptoms, physical exam findings, and
diagnostic methods to confirm PTL/PPROM
 Describe the management of PTL based on gestational age
 Describe the counseling for reducing preterm birth risk in future
pregnancy
 Describe the management of PROM based on gestational age
 Describe the risks and benefits of expectant management versus
immediate delivery following PROM
 List the indications and contraindications of medications used in
PTL and/or PROM
Case

32yo G3P1011 at 26 weeks 2 days by LMP and 6 week


ultrasound presents to the hospital.
HPI: feeling tightening of her abdomen every 5-10
minutes, somewhat painful, for the last hour; feels
some fetal movement; denies vaginal bleeding;
unsure if she had some leaking of fluid
What is PTL?

Preterm Labor
 Preterm: Less than 37 weeks gestation (extreme preterm <28
weeks)
 Labor: Regular contractions with cervical change
Leading cause neonatal morbidity in developed
countries
 40-50% preterm birth
Adverse Outcomes in Preterm Birth
 Neonatal morbidity: RDS, hypothermia, hypoglycemia,
jaundice, IVH, NEC, BPD, sepsis, PDA, seizures, CP,
retinopathy of prematurity
Case

32yo G3P1011 at 26.2 weeks by LMP and 6 week


ultrasound presents to the hospital.
HPI: feeling tightening of her abdomen every 5-10
minutes, somewhat painful, for the last hour; feels
some fetal movement; denies vaginal bleeding;
unsure if she had some leaking of fluid
What do we do from here?
 OB history, Gyn history, PMH, PSH, Meds, Allergies, SH, FH
Work up for PTL

History:
 Gestational age
 Symptoms
 Risk factors
Why does PTL occur?

Risks:  Uterine malformations:


 Prior PTD bicornuate, didelphys, fibroids
 Infections:
 VB in 2nd/3rd trimester-
placenta previa or abruption
 UTIs, pyelonephritis
 BV
 Cervical insufficiency
 Chorioamnionitis (IAI)-  Maternal Smoking or illicit
ureaplasma, mycoplasma, drug use
gardnerella, peptostreptococci,  Low SES
bacteroides  Low BMI
Uterine over-distention:  Iatrogenic (medical
multiples, polyhydramnios
Causes: indications)
 Maternal or fetal HPA axis- stress
 Decidual-chorioamniotic inflammation (infection)
 Decidual hemorrhage
 Uterine distention
Case

32yo G3P1011 at 26w2d by LMP and 6 week


ultrasound presents to the hospital.
HPI: feeling tightening of her abdomen every 5-10
minutes, somewhat painful, for the last hour; feels
some fetal movement; denies vaginal bleeding;
unsure if she had some leaking of fluid
What do we do from here?
 OB history, Gyn history, PMH, PSH, Meds, Allergies, SH, FH
 Physical Exam including vital signs, EFM/Toco
Work up for PTL

History
 Gestational age
 Risk Factors
Physical exam
 Vitals
 EFM/Toco
 SSE: VB, pooling, dilation, membranes, purulent discharge
 FFN, nitrizine, cultures
 SVE
Labs
 CBC, U/A, Ucx
Imaging
 Ultrasound for position/presentation, EFW/GA, placenta, AFI, anomalies, CL
Management of PTL

If there is no fetal or maternal reason to deliver:


 Hydrate
 GBS ppx
 Steroids (decreases RDS, IVH, NEC, death)
 Betamethasone 12mg IM Q24h x2 (or dexamethasone 6mg IM Q6h x4)
 Magnesium for neuroprotection
 <32 weeks
 Tocolysis for steroids
 Contraindicated with infection, NRFHT, eclampsia, demise, fetal maturity, maternal
instability
 Nifedipine, indomethicin (<32w)
Delivery method:
 Breech:
 <26w or <1000g  vaginal delivery
 >26w or >1000g  CD (risk head entrapment)
 Cephalic  vaginal delivery
Management of PTL
Management of PTL
How to prevent PTL

Warning signs awareness


 Cramps, low/dull backache, abdominal or pelvic pressure, abd
cramping, increased discharge, ctx
Treat infections
 E.g. BV, chlamydia, UTI
Progesterone supplementation
 17-OHP weekly from 16wks (to 36w) for women with prior PTB
 Vaginal progesterone (100-200mg) if <20mm cervix at <24wks
Low dose aspirin at 12wks if:
 Prior PEC, multiples, cHTN, DM1 or 2, renal dz; consider for
autoimmune, low PAPP-A, recurrent pregnancy loss
Cerclage?

Indicated for cervical insufficiency (painless cervical


dilation)
History-indicated:
 One or more second trimester pregnancy losses related to painless
cervical dilation in the absence of labor or abruptio placentae
 Prior cerclage due to painless cervical dilation in the second trimester
Physical exam-indicated:
 Painless cervical dilation in the second trimester
 Short cervix (<20mm) before 24 weeks
Ultrasound finding with history of prior preterm birth:
 Current singleton pregnancy, prior spontaneous preterm birth at less
than 34 weeks and short cervix (<25mm) before 24 weeks
How to screen for PTL

Cervical length
Fetal fibronectin
 22-34 weeks if S/Sx of preterm labor
 False positive with: lubricant, VB, ROM, intercourse or exam
within 24h
 Collect via speculum (or blindly) from posterior fornix
 Reassuring if negative
 NPV 99% for delivery within 7d
 Bad PPV (14% for delivery within 7d)
Screening for PTL
What is PPROM?

Preterm:
 less than 37 weeks gestation
Prelabor:
 prior to onset of labor
ROM:
 rupture of membranes
3-19% deliveries, 30% preterm deliveries
Interval to labor varies by GA
 <26w: 50% labor within 1wk
 28-34w: 50% labor within 24h, 80-90% labor within 1wk
Risks for PPROM

Intrauterine infection
Prior history PPROM or PTL
Multifetal gestation
Vaginal bleeding
Trauma
Amniocentesis
Polyhydramnios
Case

32yo G3P1011 at 26w2d by LMP and 6 week


ultrasound presents to the hospital.
HPI: notes significant amount of clear fluid leaking
vaginally for the past day; denies tightening of her
abdomen; feels some fetal movement; denies vaginal
bleeding
What do we do from here?
 OB history, Gyn history, PMH, PSH, Meds, Allergies, SH, FH
 Physical Exam including vital signs, EFM/Toco
Work up for PPROM

Same as PTL
 Specific history of ROM
 Avoid digital exam (increases risk neonatal sepsis and maternal
infection, decreases latency)
 If work up negative initially, repeat after laying down for some hours-
could do tampon test (blue dye)
Differential:
 Urinary incontinence
 Increased vaginal secretions (leukorrhea)
 Increased cervical discharge
 Infection
 Exogenous fluid (semen, douche)
 Vesicovaginal fistula
Work up for PPROM
Management of PPROM

Rule out infection, abruption


Inpatient management
 Bedrest if fetal head not well applied (cord prolapse)
<34w:
 Latency antibiotics:
 IV amp 2g q6h, IV erythromycin q6h for 48h
 PO amoxicillin 250mg q6h, PO erythromycin 250mg q6h- 5 additional days (can also use
azithromycin)
 Single dose of azithryomycin?
 Steroids
 Betamethasone 12mg IM Q24h x2 (or dexamethasone 6mg IM Q6h x4)
NO TOCOLYSIS (except to give BMZ)
Delivery
 32-34w  consider delivery
 >34w or chorio/IAI, NRFHT, hemorrhage  delivery (vaginal or cesarean)
Case

32yo G3P1011 at 26 weeks 2 days by LMP and 6 week


ultrasound diagnosed with PPROM.
Admitted
Betamethasone, Magnesium
Antibiotics
Monitored on L+D
Transferred to Antepartum
Continued to have LOF
Felt pain at 28 weeks
Vaginal delivery, infant to NICU
PTL/PPROM Objectives

 Identify risk factors


 List the adverse outcomes associated with preterm birth
 List the signs and symptoms, physical exam findings, and
diagnostic methods to confirm PTL/PPROM
 Describe the management of PTL based on gestational age
 Describe the counseling for reducing preterm birth risk in future
pregnancy
 Describe the management of PROM based on gestational age
 Describe the risks and benefits of expectant management versus
immediate delivery following PROM
 List the indications and contraindications of medications used in
PTL and/or PROM
Multifetal Gestation
Multifetal Gestation: Objectives

List the risk factors for multifetal gestation


Describe the embryology of multifetal gestation
Describe maternal and fetal physiologic changes
associated with multifetal gestation
Describe diagnosis and multidisciplinary
management of multifetal gestation
Describe the potential maternal and fetal
complications and safety concerns associated with
multifetal gestation
Multifetal Gestation

Risk Factors
 AMA
 Genetics
 Assisted Reproductive Technologies
Maternal Physiologic Changes
 Blood volume increases 50-60% (only 40% increase in
singletons)
 Increased cardiac output (stroke volume)
 Increased iron needs
 Increased uterine size
 Increased shortness of breath
Multifetal Gestation

• Embryology:

Monozygotic Dizygotic
Multifetal Gestation

Monozygotic twin pregnancy


 Early embryo splits
 Chorionicity and amnionicity depend on when split occurs
 Chorion = placenta
 Amnion = sac
 Split occurs
 0-4 days: Dichorionic diamniotic (2 placentas, 2 sac)
 4-8 days: Monochorionic diamniotic (1 placenta, 2 sacs)
 8-12 days: Monochorionic monoamniotic (1 placenta, 1 sac)
 > 12 days: Conjoined twins
 Always SAME SEX (Identical twins)

Dizygotic twin pregnancy


 Dichorionic diamniotic (2 placentas, 2 sacs)
 Sometimes same sex (fraternal twins)
Multifetal Gestation

Monozygotic twin pregnancy

0-3 Days 4-8 Days 8-12


Days

Dichorionic Monochorionic Monochorionic


diamniotic diamniotic monoamniotic
Multifetal Gestation

Diagnostic testing: Ultrasound


 Used to determine chorionicity before 14 weeks
 Membrane thickness at site of insertion of amniotic
membrane into the placenta (chorion)
Lambda (λ) sign = Dichorionic T sign = Monochorionic
Multifetal Gestation

Risks (all twins)  Placental abruption


 Pre-eclampsia
 Abortion
 Anemia  Gestational diabetes (GDM)

 Cerebral Palsy  Postpartum hemorrhage

 Cesarean Delivery
(PPH)
 Postpartum Depression
 Growth Restriction
 Prematurity
 Hyperemesis gravidarum
 IVH 2x
 Preterm labor (PTL)
 Necrotizing enterocolitis
 Prelabor rupture of  RDS
membranes (PROM)  Stillbirth (5x)
 Preterm birth (PTB) 6x
 Neonatal death (7x)
 Placenta previa
Multifetal Gestation

Risks by type of twin:


Monochorionic twins
 Congenital anomalies (i.e. heart defects)
 Weight discordance
Monochorionic diamniotic
 Twin twin transfusion syndrome (TTTS)
 Twin anemia polycythemia sequence (TAPS)
 Twin reversed arterial perfusion (TRAP)
Monochorionic monoamniotic
 Cord entanglement/accident
Multifetal Gestation

Management
 Increased weight gain recommendations
Delivery
 Dichorionic/Diamniotic (DCDA) 38 wks
 Growth scan q4 weeks
Delivery
 Monochorionic/Diamniotic (MC/DA) 34-37 wks
 Growth scan q4 weeks
 Fluid/bladder scan q2 weeks (start @ 16wks) – screening TTTS
 MCA dopplers q2 weeks (start @ 20wks) – screening TAPS
 Non-stress tests weekly (start @ 32wks)

 Monochorionic/Monoamniotic (MC/MA) Delivery


 Above + 32-34 wks
 Inpatient management @ 24-28 wks Cesarean
Multifetal Gestation

Management: Mode of delivery


 Depends on presentation of presenting twin (Twin A)
 Vertex-vertex  Vaginal delivery
 Vertex/Breech or Transverse  Vaginal or Cesarean
 Vaginal IF < 20% weight discordance, provider trained in breech
extraction
 Non-vertex Twin A  Cesarean section
Multifetal Gestation- Case

36yo G2P1001 at 12w3d gestation found to have a dichorionic


diamniotic twin gestation.
 What did the ultrasound look like to determine this?
 Lambda sign
 Can you tell zygoticity from this ultrasound?
 No
 If it was a monozygotic pregnancy, when did the split occur?
 Between 0-3 days
 What are her risks factors of having a twin gestation?
 Age >35
 What do you recommend for the patient during her prenatal care?
 Increased weight gain (37-54lb if BMI 18.5-25)
 Iron supplementation, consider calcium supplementation
Multifetal Gestation- Case

36yo G2P1001 at 12w3d gestation found to have a dichorionic


diamniotic twin gestation.
 What is she at risk of during the pregnancy?
 Preeclampsia, GDM, anemiaWhat are the risks to the fetus?

 Preterm delivery, growth restriction, stillbirth


 What do you recommend for prenatal monitoring
 Growth ultrasounds
 Can she have a vaginal delivery?
 Yes, if first twin is cephalic
 When should she deliver?
 38 weeks
 What are her risks at the time of delivery?
 Hemorrhage, cesarean delivery
Questions?

Thank you! Good Luck!

You might also like